"At the start of 2020, Moderna was a waning biotech unicorn, still years away from delivering its first product despite a decade of development of a potentially breakthrough innovation: using RNA to combat disease. Investors were getting antsy or, worse, skeptical. Then the coronavirus pandemic hit, and Moderna became a central player in a global drama-a David to pharma's Goliaths-turning its technology toward breaking the global grip of the terrible disease. By year's end, as the outbreak was at its worst, Moderna ...
Read More
"At the start of 2020, Moderna was a waning biotech unicorn, still years away from delivering its first product despite a decade of development of a potentially breakthrough innovation: using RNA to combat disease. Investors were getting antsy or, worse, skeptical. Then the coronavirus pandemic hit, and Moderna became a central player in a global drama-a David to pharma's Goliaths-turning its technology toward breaking the global grip of the terrible disease. By year's end, as the outbreak was at its worst, Moderna delivered one of the world's first Covid-19 vaccines, with a stunningly high rate of protection. The achievement not only offered the world a way out of a crippling pandemic but also validated Moderna's gene-based technology, transforming the company into a global industry power, swelling its market value on its prospects for new drugs and vaccines for years to come. Biotech, and the venture capital community that fuels it, will never be the same. Wall Street Journal reporter Peter Loftus, part of a Pulitzer Prize-finalist reporting team and 25-year veteran reporter in the pharmaceutical and biotech industries, brings the inside story of how Moderna went all in on a single revolutionary idea; of quiet research with unknown consequence; of the evolution of a cutting-edge American innovation, industry, and economy-decades in the making-that led to one of the great gambles in business history"--
Read Less
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $20.24, very good condition, Sold by Seagull Bookshop rated 5.0 out of 5 stars, ships from Hove, EAST SUSSEX, UNITED KINGDOM, published 2022 by Harvard Business Review Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very Good in Very Good jacket. Size: 6x1x10; Has some light general reading/shelfwear-otherwise this is a clean, tight copy. Quick dispatch from the UK.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $19.27, like new condition, Sold by GreatBookPricesUK5 rated 4.0 out of 5 stars, ships from Castle Donington, DERBYSHIRE, UNITED KINGDOM, published 2022 by Harvard Business Review Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Sewn binding. Cloth over boards. 320 p. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $8.28, good condition, Sold by Goodwill of Greater Milwaukee rated 5.0 out of 5 stars, ships from Milwaukee, WI, UNITED STATES, published 2022 by Harvard Business Review Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
The cover has visible markings and wear. The dust jacket is clean and undamaged. The pages are in Good condition but show signs of gentle use! Codes or product keys that accompany this product may not be valid. Fast Shipping in a Standard Poly Mailer!
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $8.50, very good condition, Sold by Bookmonger.Ltd rated 5.0 out of 5 stars, ships from Hillside, NJ, UNITED STATES, published 2022 by Harvard Business Review Press.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $9.23, like new condition, Sold by ThriftBooks-Dallas rated 5.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 2022 by Harvard Business Review Press.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $9.23, very good condition, Sold by ThriftBooks-Atlanta rated 5.0 out of 5 stars, ships from Austell, GA, UNITED STATES, published 2022 by Harvard Business Review Press.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $9.23, very good condition, Sold by ThriftBooks-Reno rated 5.0 out of 5 stars, ships from Reno, NV, UNITED STATES, published 2022 by Harvard Business Review Press.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $9.23, very good condition, Sold by ThriftBooks-Dallas rated 5.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 2022 by Harvard Business Review Press.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $9.23, very good condition, Sold by ThriftBooks-Baltimore rated 5.0 out of 5 stars, ships from Halethorpe, MD, UNITED STATES, published 2022 by Harvard Business Review Press.
Add this copy of The Messenger: Moderna, the Vaccine, and the Business to cart. $14.50, very good condition, Sold by HPB-Ruby rated 5.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 2022 by Harvard Business Review Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
